These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 8662796)
1. Ligand-independent activation of transforming growth factor (TGF) beta signaling pathways by heteromeric cytoplasmic domains of TGF-beta receptors. Feng XH; Derynck R J Biol Chem; 1996 May; 271(22):13123-9. PubMed ID: 8662796 [TBL] [Abstract][Full Text] [Related]
2. Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta. Saitoh M; Nishitoh H; Amagasa T; Miyazono K; Takagi M; Ichijo H J Biol Chem; 1996 Feb; 271(5):2769-75. PubMed ID: 8576253 [TBL] [Abstract][Full Text] [Related]
4. Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling. Blobe GC; Schiemann WP; Pepin MC; Beauchemin M; Moustakas A; Lodish HF; O'Connor-McCourt MD J Biol Chem; 2001 Jul; 276(27):24627-37. PubMed ID: 11323414 [TBL] [Abstract][Full Text] [Related]
5. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity. Feng XH; Derynck R EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801 [TBL] [Abstract][Full Text] [Related]
6. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308 [TBL] [Abstract][Full Text] [Related]
7. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region. Wieser R; Attisano L; Wrana JL; Massagué J Mol Cell Biol; 1993 Dec; 13(12):7239-47. PubMed ID: 8246946 [TBL] [Abstract][Full Text] [Related]
8. Homomeric interactions between type II transforming growth factor-beta receptors. Chen RH; Derynck R J Biol Chem; 1994 Sep; 269(36):22868-74. PubMed ID: 7521335 [TBL] [Abstract][Full Text] [Related]
9. Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-beta receptors. Chen RH; Moses HL; Maruoka EM; Derynck R; Kawabata M J Biol Chem; 1995 May; 270(20):12235-41. PubMed ID: 7744874 [TBL] [Abstract][Full Text] [Related]
10. Chimeric granulocyte/macrophage colony-stimulating factor/transforming growth factor-beta (TGF-beta) receptors define a model system for investigating the role of homomeric and heteromeric receptors in TGF-beta signaling. Anders RA; Leof EB J Biol Chem; 1996 Sep; 271(36):21758-66. PubMed ID: 8702972 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor. Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125 [TBL] [Abstract][Full Text] [Related]
14. A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor. Muramatsu M; Yan J; Eto K; Tomoda T; Yamada R; Arai K Mol Biol Cell; 1997 Mar; 8(3):469-80. PubMed ID: 9188099 [TBL] [Abstract][Full Text] [Related]
15. A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-beta ligands. Bassing CH; Howe DJ; Segarini PR; Donahoe PK; Wang XF J Biol Chem; 1994 May; 269(21):14861-4. PubMed ID: 8195115 [TBL] [Abstract][Full Text] [Related]
16. Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers. Stockwell BR; Schreiber SL Curr Biol; 1998 Jun; 8(13):761-70. PubMed ID: 9651680 [TBL] [Abstract][Full Text] [Related]
17. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. Luo K; Lodish HF EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding. De Crescenzo G; Pham PL; Durocher Y; O'Connor-McCourt MD J Mol Biol; 2003 May; 328(5):1173-83. PubMed ID: 12729750 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. Bourguignon LY; Singleton PA; Zhu H; Zhou B J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287 [TBL] [Abstract][Full Text] [Related]
20. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta. Yamashita H; Ichijo H; Grimsby S; Morén A; ten Dijke P; Miyazono K J Biol Chem; 1994 Jan; 269(3):1995-2001. PubMed ID: 8294451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]